Astera Labs (NASDAQ:ALAB) Shares Gap Up on Analyst Upgrade

Astera Labs, Inc. (NASDAQ:ALAB)’s share price gapped up prior to trading on Wednesday after Zacks Research upgraded the stock from a hold rating to a strong-buy rating. The stock had previously closed at $311.99, but opened at $334.49. Astera Labs shares last traded at $331.49, with a volume of 1,007,863 shares traded.

Several other equities research analysts also recently weighed in on the stock. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Evercore reaffirmed an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. UBS Group reissued a “neutral” rating and issued a $425.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Morgan Stanley boosted their target price on Astera Labs to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. Finally, Jefferies Financial Group boosted their target price on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and a consensus price target of $325.25.

Insider Transactions at Astera Labs

In other news, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $311.83, for a total value of $1,092,964.15. Following the completion of the sale, the director owned 53,961 shares of the company’s stock, valued at $16,826,658.63. This represents a 6.10% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 8,491 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $458.38, for a total transaction of $3,892,104.58. Following the completion of the sale, the director directly owned 286,863 shares in the company, valued at $131,492,261.94. This trade represents a 2.87% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 1,256,894 shares of company stock valued at $362,763,135. 10.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Reflection Asset Management purchased a new position in shares of Astera Labs during the fourth quarter worth about $25,000. Keating Financial Advisory Services Inc. acquired a new position in shares of Astera Labs in the second quarter valued at approximately $25,000. Smartleaf Asset Management LLC raised its position in Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new position in Astera Labs during the fourth quarter worth about $33,000. Finally, Whipplewood Advisors LLC lifted its holdings in shares of Astera Labs by 15,950.0% in the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after buying an additional 319 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Stock Up 1.2%

The business has a fifty day simple moving average of $357.91 and a 200 day simple moving average of $239.63. The company has a market cap of $56.00 billion, a price-to-earnings ratio of 159.79 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same period in the prior year, the business posted $0.44 earnings per share. The firm’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.